Screener
Agios Pharmaceuticals AGIO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's return on equity?
- Agios Pharmaceuticals (AGIO) reported return on equity of -34.3% in Q2 2026.
- What is the long-term trend for Agios Pharmaceuticals's return on equity?
- Over 3 years (2020 to 2025), Agios Pharmaceuticals's return on equity has grown at a -21.7% compound annual growth rate (CAGR), from -63% to -30.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Agios Pharmaceuticals's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude